| 0.3358 -0.014 (-4.06%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.55 | 1-year : | 0.67 |
| Resists | First : | 0.47 | Second : | 0.57 |
| Pivot price | 0.4  |
|||
| Supports | First : | 0.31 | Second : | 0.26 |
| MAs | MA(5) : | 0.35 |
MA(20) : | 0.39 |
| MA(100) : | 0.73 |
MA(250) : | 1.5 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1  |
| %K %D | K(14,3) : | 8.4 |
D(3) : | 12.5 |
| RSI | RSI(14): 37.6 |
|||
| 52-week | High : | 4.71 | Low : | 0.31 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MYNZ ] has closed above bottom band by 14.4%. Bollinger Bands are 26.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.36 - 0.36 | 0.36 - 0.36 |
| Low: | 0.32 - 0.32 | 0.32 - 0.32 |
| Close: | 0.33 - 0.34 | 0.34 - 0.34 |
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Sat, 20 Jul 2024
Mainz Biomed (NASDAQ:MYNZ) Shares Down 8.2% - American Banking and Market News
Tue, 09 Jul 2024
Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test - Markets Insider
Tue, 02 Jul 2024
Mainz Biomed reports progress in colorectal cancer diagnostics - Investing.com
Tue, 04 Jun 2024
Mainz Biomed shares target halved, retains Buy rating on funding concerns - Investing.com
Fri, 31 May 2024
Mainz Biomed Reports Results of 2024 Annual General Meeting - Yahoo Finance
Tue, 05 Dec 2023
Mainz Biomed stock falls on U.S. trial data for cancer test - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 0 (M) |
| Shares Float | 22 (M) |
| Held by Insiders | 1.839e+007 (%) |
| Held by Institutions | 21.6 (%) |
| Shares Short | 426 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.607e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -3 % |
| Return on Assets (ttm) | 68.7 % |
| Return on Equity (ttm) | -93.5 % |
| Qtrly Rev. Growth | 895480 % |
| Gross Profit (p.s.) | 79.28 |
| Sales Per Share | -2165.72 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -1.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 0.31 |
| Dividend | 0 |
| Forward Dividend | 387760 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|